Randomized trial of technology-assisted self-monitoring of blood glucose by low-income seniors: improved glycemic control in type 2 diabetes mellitus. J Behav Med 2016 Dec;39(6):1001-1008
Date
07/03/2016Pubmed ID
27368257DOI
10.1007/s10865-016-9763-5Scopus ID
2-s2.0-84976519221 (requires institutional sign-in at Scopus site) 7 CitationsAbstract
Self-monitoring of blood glucose (SMBG) has been recommended for people with type 2 diabetes mellitus. This trial tested an automated self-management monitor (ASMM) that reminds patients to perform SMBG, provides feedback on results of SMBG, and action tips for improved self-management. This delayed-start trial randomized participants to using the ASMM immediately (IG), or following a delay of 6 months (DG). Glycated hemoglobin (HgbA1c) level and survey data was collected at home visits every 3 months. 44 diabetic men and women, mean age 70, completed the 12-month trial. Baseline HgbA1c was 8.1 % ± 1.0, dropping to 7.3 ± 1.0 by 9 months, with a 3-month lag in the DG (F = 3.56, p = 0.004). Decrease in HgbA1c was significantly correlated to increased frequency of SMBG, R = 0.588, p < 0.01. Providing older diabetics with objective immediate contingent feedback resulted in more frequent SMBG that correlated with better glycemic control. This type of technology may provide real-time feedback not only to patient users, but to the health care system, allowing better integration of provider recommendations with patient-centered action.
Author List
Levine JC, Burns E, Whittle J, Fleming R, Knudson P, Flax S, Leventhal HAuthors
Paul Knudson MD Associate Professor in the Medicine department at Medical College of WisconsinJeffrey Whittle MD Professor in the Medicine department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AgedBlood Glucose Self-Monitoring
Diabetes Mellitus, Type 2
Female
Humans
Male
Poverty
Self Care
Software
Surveys and Questionnaires
